Intra-Cellular Therapies Inc.
ITCI
ITCI was delisted on the 1st of April, 2025.
91 hedge funds and large institutions have $577M invested in Intra-Cellular Therapies Inc. in 2015 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 8 closing their positions.
261% more call options, than puts
Call options by funds: $6.08M | Put options by funds: $1.69M
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
118% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 17
43% more capital invested
Capital invested by funds: $405M → $577M (+$173M)
23% more funds holding
Funds holding: 74 → 91 (+17)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$12.5M |
| 2 |
PC
Pier Capital
Stamford,
Connecticut
|
+$6.52M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$4.36M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.22M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$2.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$10.7M |
| 2 |
BG
BlackRock Group
London,
United Kingdom
|
-$3.68M |
| 3 |
FAM
Fred Alger Management
New York
|
-$3.36M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.54M |
ITCI Hedge Fund Activity: Q2 2015 in Review
91 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q2 2015, worth a combined $577M — up 43% from $405M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ITCI positions and 8 closed out — a net gain of 17 holders — while 37 added to existing stakes and 17 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $12.5M. The largest seller was BlackRock Advisors, cutting an estimated $10.7M.
- 91 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q2 2015, up from 74 in Q1 2015.
- Funds reported $577M of Intra-Cellular Therapies Inc. stock for Q2 2015, up 43% quarter-over-quarter.
- 25 funds opened new Intra-Cellular Therapies Inc. positions in Q2 2015 and 8 closed out, a net change of +17 holders.
- The largest Intra-Cellular Therapies Inc. buyer in Q2 2015 was Millennium Management, an estimated $12.5M added.
- The largest Intra-Cellular Therapies Inc. seller in Q2 2015 was BlackRock Advisors, an estimated $10.7M sold.
Based on aggregated 13F filings for Q2 2015.